Seeing Is Believing
ATNM is currently covered by 1 analysts with an average price target of $2.76. This is a potential upside of $1.13 (69.33%) from yesterday's end of day stock price of $1.63.
Actinium Pharmaceuticals's activity chart (see below) currently has 0 price targets and 18 ratings on display. The stock rating distribution of ATNM is 100% BUY.
Highest price target for ATNM is $4, Lowest price target is $4, average price target is $2.76.
Most recent stock forecast was given by JOSEPH PANTGINIS from HCWAINWRIGHT on 06-Aug-2024. First documented stock forecast 04-Jun-2020.
Currently out of the existing stock ratings of ATNM, 15 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$4
$2.21 (123.46%)
$50
2 months 5 days ago
0/15 (0%)
$1.13 (39.37%)
What is ATNM (Actinium Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ATNM (Actinium Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ATNM (Actinium Pharmaceuticals)?
Which analyst is the currently most bullish on ATNM (Actinium Pharmaceuticals)?